Pharmacological Chaperones for the Treatment of α-Mannosidosis-Reference-Cited by-同舟云学术

Pharmacological Chaperones for the Treatment of α-Mannosidosis

Published:2019-04-24 Issue:12 Volume:62 Page:5832-5843
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Rísquez-Cuadro Rocío¹,Matsumoto Reimi²,Ortega-Caballero Fernando¹,Nanba Eiji²,Higaki Katsumi²,García Fernández José Manuel³^ORCID,Ortiz Mellet Carmen¹^ORCID

Affiliation:

1. Department of Organic Chemistry, Faculty of Chemistry, University of Sevilla, C/ Profesor García González 1, 41012 Sevilla, Spain

2. Organization for Research Initiative and Promotion, Tottori University, 86 Nishi-cho, Yonago 683-8503, Japan

3. Instituto de Investigaciones Químicas (IIQ), CSIC—Universidad de Sevilla, Avda. Américo Vespucio 49, Isla de la Cartuja, 41092 Sevilla, Spain

Funder

European Regional Development Fund

Consejer?a de Econom?a, Innovaci?n, Ciencia y Empleo, Junta de Andaluc?a

Ministerio de Econom?a y Competitividad

Japan Society for the Promotion of Science

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.9b00153

Reference76 articles.

1. Lysosomal alpha-mannosidase and alpha-mannosidosis

2. Alpha-Mannosidosis: Therapeutic Strategies

3. Analysis of urinary oligosaccharides in lysosomal storage disorders by capillary high-performance anion-exchange chromatography–mass spectrometry

4. Heterogeneity of urinary oligosaccharides from mannosidosis: Mass spectrometric analysis of permethylated Man9, Man8, and Man7 derivatives

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. sp2-Iminosugar azobenzene O-glycosides: Light-sensitive glycosidase inhibitors with unprecedented tunability and switching factors;Bioorganic Chemistry;2024-09

2. Multivalent pyrrolidines acting as pharmacological chaperones against Gaucher disease;Bioorganic Chemistry;2024-05

3. Velmanase alfa approved for treatment of non-central nervous system manifestations of alpha-mannosidosis: A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG);Genetics in Medicine Open;2024

4. High‐Mannose Oligosaccharide Hemimimetics that Recapitulate the Conformation and Binding Mode to Concanavalin A, DC‐SIGN and Langerin;Chemistry – A European Journal;2023-11-14

5. Carbohydrate‐Based Therapeutics for Lysosomal Storage Disorders;Carbohydrate‐Based Therapeutics;2023-09-05